Results 11 to 20 of about 72,557 (166)
Heterojunction Nanomedicine [PDF]
Advanced Science, 2022 AbstractExogenous stimulation catalytic therapy has received enormous attention as it holds great promise to address global medical issues. However, the therapeutic effect of catalytic therapy is seriously restricted by the fast charge recombination and the limited utilization of exogenous stimulation by catalysts.
Chao Pan +5 more
openaire +3 more sources
New England Journal of Medicine, 2010 Many diseases originate from alterations in biologic processes at the molecular or nanoscale level. Mutated genes, misfolded proteins, and infections caused by viruses or bacteria can lead to cell malfunction or miscommunication, sometimes leading to life-threatening diseases.
Kim, Betty Y. S. +2 more
openaire +3 more sources
Nanoproteomics for Nanomedicine [PDF]
Nanomedicine, 2010 677 ISSN 1743-5889 Nanomedicine (2010) 5(5), 677–682 10.2217/NNM.10.46 © 2010 Future Medicine Ltd “Label-free NAPPA technology, in combination with protein nanobiocrystallography and its possible future development using anodic porous alumina along with a cell-free expression system ...
NICOLINI, CLAUDIO, PESHKOVA, EVGENIYA
openaire +3 more sources
Personalized Nanomedicine [PDF]
Clinical Cancer Research, 2012 Abstract Personalized medicine aims to individualize chemotherapeutic interventions on the basis of ex vivo and in vivo information on patient- and disease-specific characteristics. By noninvasively visualizing how well image-guided nanomedicines—that is, submicrometer-sized drug delivery systems containing both drugs and imaging agents ...
Lammers, T. +3 more
openaire +4 more sources
Nanotechnology, 2020 Since the launch of the Alliance for Nanotechnology in Cancer by the National Cancer Institute in late 2004, several similar initiatives have been promoted all over the globe with the intention of advancing the diagnosis, treatment and prevention of cancer in the wake of nanoscience and nanotechnology.
Paolo Decuzzi +19 more
openaire +6 more sources
Cancers, 2020 This Special Issue on Cancer Nanomedicine within Cancers brings together 46 cutting-edge papers covering research within the field along with insightful reviews and opinions reflecting our community [...]
openaire +5 more sources
Nanomedicine, 2007 As the science and technology of nanomedicine speed ahead, ethics, policy and the law are struggling to keep up. It is important to proactively address the ethical, social and regulatory aspects of nanomedicine in order to minimize its adverse impacts on the environment and public health and also to avoid a public backlash.
David B, Resnik, Sally S, Tinkle
openaire +2 more sources
Fucoidans in Nanomedicine [PDF]
Marine Drugs, 2016 Fucoidans are widespread cost-effective sulfated marine polysaccharides which have raised interest in the scientific community over last decades for their wide spectrum of bioactivities. Unsurprisingly, nanomedicine has grasped these compounds to develop innovative therapeutic and diagnostic nanosystems. The applications of fucoidans in nanomedicine as
Chollet, Lucas +5 more
openaire +5 more sources
Nanomedicine and Society [PDF]
Clinical Pharmacology & Therapeutics, 2009 Nanomedicine is a reality of medical research and clinical practice, and it offers new and promising approaches to fundamental problems in medicine. Most prominent are the early detection of neoplastic disease and the individualized treatment of metastases. These potentially transformational developments require careful scrutiny of the potential impact
Ferrari, M, Philibert, MA, Sanhai, WR
openaire +3 more sources